Gabrielle Stearns

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

The latest issue of Oncology Issues features key insights from the inaugural ACCC Leadership Summit, strategies to adjust to rising patient volumes and workforce strain, advanced practice leadership models, and more.

In the third in a series of multidisciplinary consensus-building roundtables, ACCC and its partners explored ways to bridge the gap between community oncology programs and authorized treatment centers offering CAR T for patients with multiple myeloma.

In the recent NCCN policy summit "Health Literacy in the Cancer Care Digital Age," speakers and panelists discussed how best to communicate with patients and foster the responsible use of emerging technologies, with a strong focus on shared decision-making.

On Friday, April 17, ACCC welcomed oncology leaders from around the country to Washington, DC for the inaugural ACCC Leadership Summit, a forum designed for executive-level decision-makers to engage in strategic dialogue, peer-to-peer exchange, and actionable insights at the highest level of oncology leadership.

From Ghana to Orlando, experts across the multidisciplinary care team share how they are expanding access to clinical trials and supportive care services and improving quality of life for their patients as a result in this Oncology Issues. Read on for a preview of this issue’s articles and dive deeper to learn from colleagues across the country and the globe.

On day 1 of the NCCN 2026 Annual Conference, attendees heard from experts on the unique issues young adults with cancer face during and post-treatment, advances in treating gastrointestinal cancers, evolving therapies in skin cancers, and novel approaches to treating blood cancers.

ACCCBuzz interviewed leadership from the National Association of Veterans’ Research and Education Foundations to better understand the current clinical and operational barriers Veterans face in accessing clinical trials and the progress being made to address them.

The newest Oncology Issues is here, opening the year with a spotlight on the six 2025 ACCC Innovators: Fox Chase Cancer Center, Lifepoint Health, Penn Medicine Princeton Health, WellSpan Cancer Institute, Highlands Oncology, and Shaw Cancer Center.

This National Cancer Prevention Month, it is vital that the oncology community identify effective and sustainable strategies to encourage prevention measures and reduce the burden of cancer on both individuals and a strained health care infrastructure.

The NCCN hosted a patient advocacy summit as a forum for providers, advocates, and industry members to discuss the varied and unique cancer care needs of Veterans and first responders.

This installment of Oncology Issues emphasizes collaboration, whether between oncology and other medical specialties, between surgeons, or between the cancer care community and policy makers.

In recognition of Bladder Health Awareness Month, ACCC shares the results of a recent quality improvement study, which provides impactful steps cancer centers can take to mitigate disparities in bladder cancer.

The Vol 40 No 5 issue of the Association of Cancer Care Centers’ (ACCC) peer-reviewed, bimonthly journal, Oncology Issues, has 7 feature articles offering insights and solutions that are valuable to every member of the multidisciplinary cancer care team.

Breast Cancer Awareness Month, observed each year in October, recognizes the research, advocacy, and strength of patients that have led to treatment advances for the most common cancer diagnosis in women.

The NCCN hosted a 1-day summit on September 9 all about AI in cancer care: how it’s being used today, where the field is moving in the future, and challenges that will require innovative and collaborative solutions.

In honor of Hereditary Cancer Awareness Week, observed this year from September 29 to October 5, ACCC is highlighting 2 initiatives from its member programs that expanded genetic testing for hereditary cancers.

September is Blood Cancer Awareness month, an opportunity to spotlight the broad category of diseases that include leukemia, lymphoma, plasma cell neoplasms, myelodysplastic syndromes, and myeloproliferative neoplasms.

Advanced practice providers (APPs) are essential members of the cancer care team with roles that vary depending on institutional policies and state regulations. Empowering APPs to work at the top of their scope leads to stronger care delivery.

Despite the best intentions of their providers, patients and caregivers often report feeling uncertain, unsupported, or overwhelmed during treatment selection for CLL—an important part of the patient journey.